Treatment of COVID-19: Cuban Drug Itolizumab Proves Effective in Critically Ill Patients
The Ministry of Public Health announced that the Cuban drug Itolizumab – developed by the Center for Molecular Immunology (CIM) – has shown positive results as an anti-inflammatory treatment in patients with COVID-19. According to a study published on the
Read More